Delivery Order N0018925DZ006-W81K0426FA264
Award Date 5/30/26
Potential Completion Date 8/31/26
Potential Value $17K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fort Meade, MD 20755, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of the Army issued a delivery order to Microgenics Corporation on January 22, 2026, for DRI amphetamine assay reagent kits, with a ceiling value of $8,406.00 and ultimate completion date of February 6, 2026. Place of performance is Fort Meade, MD. The order is firm fixed price with no set-aside. Microgenics Corporation, a clinical diagnostics manufacturer specializing in immunoassay reagent test kits for substance detection, holds a portfolio of single-award indefinite delivery...
- The Defense Health Agency awarded a $22,416 firm fixed-price delivery order to Microgenics Corporation on May 13, 2025, for d-amphetamine and d-methamphetamine immunoassay reagent kits to support the Tripler Army Medical Center (TAMC) Forensic Toxicology Drug Testing Laboratory. The contract, which carries an ultimate completion date of August 26, 2025, represents a delivery order under a larger indefinite delivery vehicle and does not utilize a set-aside designation. Microgenics, a clinical...
- The Navy Bureau of Medicine and Surgery awarded a $12,889.20 firm fixed-price delivery order to Microgenics Corporation for EMIT II PLUS amphetamine and methamphetamine reagent kits in support of the Department of Defense Drug Demand Reduction Program. The contract, awarded on September 6, 2025, with an ultimate completion date of September 18, 2025, represents a delivery order under an existing indefinite delivery vehicle. Microgenics Corporation, a clinical diagnostics subsidiary of Thermo...
- The Defense Health Agency awarded a delivery order valued at $8,134.80 to Microgenics Corporation, a subsidiary of Thermo Electron Corporation, for DRI opiate reagent kits to be delivered to Fort Meade, Maryland. The contract, effective June 1, 2025, with an ultimate completion date of May 31, 2028, is structured as a firm fixed-price delivery order with no set-aside designation. Microgenics, headquartered in Fremont, California, is a specialized manufacturer of clinical diagnostic products...
- The U.S. Navy Bureau of Medicine and Surgery awarded a delivery order valued at $10,087.20 to Microgenics Corporation for EMIT II PLUS Amphetamine and Methamphetamine Reagent Kits on December 22, 2025. This firm fixed-price delivery order, with an ultimate completion date of January 8, 2026, does not utilize a set-aside designation. Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation based in Fremont, California, specializes in manufacturing high-precision...
- Microgenics Corporation's Clinical Diagnostics Division was awarded a firm fixed-price delivery order valued at $8,406.00 by the Navy Bureau of Medicine and Surgery for amphetamine and methamphetamine reagent kits (Part Number 0018PSC). The contract carries no set-aside designation, reflecting Microgenics' competitive position in the federal diagnostic reagent marketplace. Performance will be completed at the contractor's Fremont, California facility, with an ultimate completion date of November...
- The U.S. Navy has awarded a delivery order valued at $22,416 to Microgenics Corporation, a subsidiary of Thermo Electron Corporation and a Clinical Diagnostics Division specialist, for the supply of amphetamine and methamphetamine reagent kits. This order, issued December 11, 2025, with an ultimate completion date of September 15, 2026, is issued under Navy Contract N0018925DZ006, an Indefinite Delivery Indefinite Quantity (IDIQ) agreement, and carries no set-aside designation. Performance...
- Microgenics Corporation, a subsidiary of Thermo Electron Corporation and a leading manufacturer of clinical diagnostic products, received a delivery order award from the Navy Bureau of Medicine and Surgery for amphetamine and methamphetamine reagent kits. The contract, valued at $1,401.00 with a completion date of January 30, 2025, is a firm fixed-price delivery order with no set-aside designation. The kits will be delivered to the place of performance in North Chicago, Illinois, and represent a...
- Microgenics Corporation, through its Clinical Diagnostics Division, was awarded a firm fixed-price delivery order valued at $11,388.72 by the Air Education and Training Command (AETC) for DRI Opiate 500ML Reagent Test Kits (MFG Part Number 0136). The delivery order, issued on May 16, 2025, with an ultimate completion date of October 16, 2025, carries no set-aside designation, reflecting Microgenics' competitive standing in the federal marketplace. Performance will occur at Lackland Air Force...
- The U.S. Navy Bureau of Medicine and Surgery awarded a delivery order valued at $12,518.40 to Microgenics Corporation on August 1, 2025, for MDMA/MDA reagent kits (Part Number 10024631PSC). This firm fixed-price delivery order, with an ultimate completion date of August 12, 2025, will be performed in Fremont, California, and does not utilize a set-aside designation. Microgenics Corporation, a clinical diagnostics division subsidiary of Thermo Electron Corporation, specializes in manufacturing...